Publications

RESPONSE: Comparing the Dosages of Lacosamide, Eslicarbazepine Acetate, and Controlled-Release Carbamazepine in Noninferiority Epilepsy Monotherapy Trials: How Much "Fair" Is "Fair"

AuthID
P-00N-TC4

Author(s)

Trinka, E

Rocha, JF

Soares da Silva, P

Document Type

Letter

Year published

2018

Published

in EPILEPSIA, ISSN: 0013-9580

Volume: 59, Issue: 4, Pages: 900-901 (2)

Indexing

Wos^®

Scopus^®

Crossref^®

Google Scholar^®

Publication Identifiers

DOI: 10.1111/epi.14062

Scopus: 2-s2.0-85044670444

Wos: WOS:000428847900023

Source Identifiers

ISSN: 0013-9580

Export Publication Metadata

Marked List

Add to Marked List

Citations

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference

No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors

Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text

Full Text @ sfx.b-on.pt

RESPONSE: Comparing the Dosages of Lacosamide, Eslicarbazepine Acetate, and Controlled-Release Carbamazepine in Noninferiority Epilepsy Monotherapy Trials: How Much "Fair" Is "Fair"

Useful Links

Get Help

Federated Authentication (Click on the image)

RESPONSE: Comparing the Dosages of Lacosamide, Eslicarbazepine Acetate, and Controlled-Release Carbamazepine in Noninferiority Epilepsy Monotherapy Trials: How Much "Fair" Is "Fair"

Useful Links

Get Help